ArticleBMC nephrology2025
Adopting orphan deceased donor kidneys for transplantation.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney transplantation is the best option for overcoming kidney replacement therapy in the end stage kidney disease population. Yet the number of available kidney donors remains limited. The use of aggressive kidney offers could serve as an alternative to address the shortage of donors and reduce the rate organ non-use.
methodsWe retrospectively analyzed ten kidneys that were aggressively offered to our transplant center before being included in the non-usable organ pool. They were transplanted in a short period of time. Donor and recipient demographics, intraoperative data, and recipient outcomes were included in the analysis.
resultsTen orphan kidneys were transplanted into appropriate recipients from three deceased kidney after cardiac death and three from brain death donors. The median cold ischemia time was 2,216 min, and median warm ischemia time was 25 min. Five recipients experienced delayed graft function. The median creatinine levels were 1.5 mg/dl, 1.5 mg/dL, and 1.4 mg/dL at 3, 6 and 12 months.
conclusionsWe successfully transplanted ten kidneys that otherwise would have been classified within the UNOS organ non-use rate. Several factors contributed to the successful utilization of these kidneys, including kidney biopsies, hypothermic machine perfusion, treatment during machine perfusion, and careful selection of appropriate recipients by the transplant team. The non-use kidney pool presents a valuable opportunity for enhancing kidney utilization for transplantation and increasing organ availability. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.